For academic researchers

Peptide Research Services for Academic Principal Investigators

Academic research groups often have the most important scientific insights — validated targets, novel mechanisms, and published data that could form the basis of a therapeutic peptide program. What they typically lack is the computational infrastructure and development expertise to translate those insights into development-ready candidates. We bridge that gap.

The Academic Translation Gap

Academic peptide research generates enormous scientific value — but most of it never reaches patients. The gap between a published peptide finding and a development-ready candidate is wide: it requires computational design infrastructure, medicinal chemistry expertise, and translational science that most academic groups do not have in-house.

External peptide research partnerships allow academic groups to access these capabilities without the overhead of building them internally — enabling translation of academic discoveries into development-ready candidates that can attract industry partners or form the basis of a spinout.

How We Work with Academic Groups

01

Publication-to-candidate translation

Taking published peptide findings — sequences, targets, mechanisms — and translating them into optimized development candidates.

02

Grant-compatible collaboration

Collaboration structures designed to work within academic grant frameworks, with appropriate IP and publication arrangements.

03

Translational readiness building

Systematic improvement of candidate properties to meet industry development criteria — the foundation for licensing or partnership.

04

IP development support

Support for patent filing and IP development to protect academic discoveries before industry engagement.

Academic Partnership Workflow

01

Project submission

Submit your target, publication, or peptide finding and research objectives.

02

Scientific review

Our team reviews the scientific basis and translational potential of the project.

03

Collaboration discussion

Discussion of approach, IP arrangements, publication rights, and collaboration structure.

04

Project proposal

Formal proposal with scope, deliverables, timeline, and collaboration terms.

05

Research execution

Computational and experimental work with regular updates and joint publications where appropriate.

06

Candidate and IP package

Development-ready candidate with data package and IP documentation.

What We Can Support

Translation of published peptide findings into development candidates
AI-assisted optimization of academic peptide leads
Translational readiness assessment and improvement
IP landscape analysis and patentability assessment
Stability, bioavailability, and selectivity optimization
Industry-ready data package preparation
Spinout and licensing preparation support

What You May Receive

Optimized peptide candidates

Development-ready candidates derived from your academic discovery.

Translational data package

Computational and experimental data meeting industry development criteria.

IP documentation

Patent application support and IP landscape analysis.

Industry engagement materials

Data package and development narrative for licensing or partnership discussions.

Deliverables depend on project scope and scientific starting point. Development outcomes cannot be guaranteed.

Who This Is For

Principal investigators

Academic PIs with validated peptide targets or published findings seeking to translate their research into development candidates.

Research groups with peptide leads

Groups that have identified promising peptide sequences and need optimization and translational development support.

Pre-spinout academic teams

Academic groups preparing to form a spinout company and needing development-ready candidates and IP to attract investment.

Frequently Asked Questions

Translate Your Academic Peptide Research

Submit your target, publication, or peptide finding. We will assess the translational potential and outline a collaboration structure suited to your academic context.

Confidential discussions available under NDA. Publication rights preserved.